Compare · ABOS vs ALZN

ABOS vs ALZN

Side-by-side comparison of Acumen Pharmaceuticals Inc. (ABOS) and Alzamend Neuro Inc. (ALZN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. ABOS focuses on Biotechnology: Biological Products (No Diagnostic Substances), while ALZN focuses on Biotechnology: Pharmaceutical Preparations.
  • ABOS is the larger of the two at $15.1M, about 2.5x ALZN ($6.0M).
  • ABOS has been more active in the news (10 items in the past 4 weeks vs 1 for ALZN).
  • ABOS has more recent analyst coverage (14 ratings vs 1 for ALZN).
MetricABOSALZN
Company
Acumen Pharmaceuticals Inc.
Alzamend Neuro Inc.
Price
-
-
Market cap
$15.1M
$6.0M
1M return
-
-
1Y return
-
-
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ
NASDAQ
IPO
2021
2021
News (4w)
10
1
Recent ratings
14
1
ABOS

Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.

ALZN

Alzamend Neuro Inc.

Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.

Latest ABOS

Latest ALZN